{
    "2019-08-22": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Abbott Dips More Than Broader Markets: What You Should Know",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Dips",
                        "Broader Markets"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Abbott's Libre Adoption a Positive, Rhythm Management a Woe",
                "features": {
                    "keywords": [
                        "Libre Adoption",
                        "Positive",
                        "Rhythm Management",
                        "Woe"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "The Zacks Analyst Blog Highlights: Home Depot, Abbott, Bristol-Myers, Activision and Marathon",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Home Depot",
                        "Bristol-Myers",
                        "Activision",
                        "Marathon"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "retail",
                        "pharmaceuticals",
                        "technology",
                        "energy"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Why Did Medtronic's Stock Grow Around 20% Over The Last 2 Years?",
                "features": {
                    "keywords": [
                        "Medtronic",
                        "Stock Growth",
                        "20%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}